A. Atanes

Anti–Interleukin‐6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis–Associated Uveitis Refractory to Anti–Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty‐Five Patients

V. Calvo-Río, Inmaculada Calvo, María Isabel González et al. · Arthritis & Rheumatology · 2016 · 152 citations

Medicine, Ophthalmology, Pharmacotherapy +17

Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients

N. Vegas-Revenga, V. Calvo-Río, Marina Mesquida et al. · American Journal of Ophthalmology · 2019 · 116 citations · Full text

Medicine, Immunology, Ophthalmology +15

Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet’s disease: multicentre retrospective study

Belén Atienza‐Mateo, V. Calvo-Río, E. Beltrán et al. · Lara D. Veeken · 2018 · 107 citations

Medicine, Immunology, Ophthalmology +17

Golimumab in refractory uveitis related to spondyloarthritis. Multicenter study of 15 patients

V. Calvo-Río, Ricardo Blanco, Esteban Rubio‐Romero et al. · Seminars in Arthritis and Rheumatism · 2016 · 92 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +12

Tocilizumab in Behçet's disease with refractory ocular and/or neurological involvement: response according to different clinical phenotypes

Belén Atienza‐Mateo, E. Beltrán, Marisa Hernández‐Garfella et al. · Clinical and Experimental Rheumatology · 2021 · 31 citations · Full text

Medicine, Neurology, Ophthalmology +9